Image Source: Free Press Journal
Metropolis Healthcare Ltd has reported a robust 11.6% yearonyear revenue growth in Q1 FY26, signaling a strong start to the fiscal year driven by higher test volumes, improved realizations, and continued traction in wellness diagnostics. The company’s total income rose to ₹319.55 crore, up from ₹286.14 crore in Q1 FY25, while net profit stood at ₹23.85 crore.
Key Highlights:
-
Topline Performance:
-
Revenue from operations grew 11.6% YoY to ₹311.95 crore
-
Total income, including other income, reached ₹319.55 crore
Profitability Metrics:
-
EBITDA stood at ₹60.34 crore, with margins improving to 18.9%
-
Net profit came in at ₹23.85 crore, down from ₹31.28 crore YoY, due to higher employee and other operating expenses
Volume & Realization Drivers:
-
Test volumes rose 7% YoY, while revenue per patient improved by 6%, aided by premium wellness packages and bundled offerings
-
The TruHealth wellness segment saw doubledigit growth, contributing significantly to B2C revenues
Strategic Focus:
-
Continued expansion in Tier II and III cities, with 12 new labs and 180 collection centers added
-
Digital initiatives and AIled diagnostics enhanced operational efficiency and patient engagement
Outlook:
Management remains optimistic about sustaining doubledigit growth, supported by network expansion, test mix optimization, and rising preventive care demand
Metropolis is scripting a steady recovery story—one diagnostic at a time.
Source: CNBCTV18, Economic Times, Moneycontrol
Advertisement
Advertisement